New molecule could reverse neurodegeneration in Parkinson’s

News

Author: Simge Eva DoganPublished: 11 October 2018

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

molecule

Researchers at a university in Spain have discovered a new molecule which they claim can block and reverse neurodegeneration in Parkinson’s.

The molecule – named SynuClean-D – is able to reduce alpha-synuclein aggregations which cause degeneration.

The study – published in science journal ‘PNAS’ – explains how researchers at the Universitat Autònoma de Barcelona, Spain, tested over 14,000 molecules before discovering SynuClean-D.

They then tested the molecule on a Caenorhabditis worm – one of the most commonly used animals when researching neurodegenerative diseases – finding that it boosted its mobility and protected it from neural degeneration.

Salvador Ventura, the study coordinator, said: “Everything seems to indicate that the molecule we identified, the SynuClean-D, may provide therapeutic applications for the treatment of neurodegenerative diseases such as Parkinson’s in the future.”

To read more on this topic click here.

For more information on the latest Parkinson’s research please visit the EPDA website.

Go Back

Share this story

Comments


Related articles


Kirk reading to his grandchildren

Interviews

World Parkinson Congress 2019 Bloggers: Kirk Hall

#WPC2019: We talk to American blogger Kirk Hall

READ MORE

Episodes

Podcast: How to eat well with Parkinson’s disease

Two guests discuss cooking with the condition

READ MORE
Ciara Clancy

Interviews

Move to the beat: meet the Parkinson’s physio behind award-winning mobility app

Giving Parkinson’s patients “the tools to take control”

READ MORE